For the nine months, revenue was USD 27.9 million, down 9% from USD 30.7 million, and net loss was USD 3.5 million against net income of USD 4.1 million.
GAAP diluted loss per share was USD 0.04, against an estimated loss of USD 0.18 and a loss of USD 0.31 a year ago, and included a USD 0.16 benefit from tariff refunds. Non-GAAPEarnings Per Sharewas USD 0.04, compared with a loss of USD …
Adjusted EBITDA was approximately negative USD 8.6 million, an improvement of 27% from negative USD 11.8 million. Operating cash use fell to USD 5 million from USD 23.4 million in the second quarter, and nine-month revenue decreased USD 3.8 million, or 7%.
The FDA approved ISEMBYLD on Friday, September 11, ahead of its target action date. The therapy is indicated for patients with spinal muscular atrophy aged two and older who are receiving an SMN2-targeted treatment. In the Phase 3 SAPPHIRE study, it delivered a 2.2-point …
Management said gross merchandise sales grew 7% to USD 2.6 billion and that GMS to revenue conversion was 19%, comparable to the prior year and up more than 60 basis points from the second quarter. Adjusted EBITDA rose 84% to USD 124 million, a …
System revenue was USD 3.0 million against USD 1.9 million, and management said roboticCapitalrevenue rose over 20% sequentially. Recurring revenue was USD 5.9 million, up 6% from a year earlier and down 4% from the second quarter, which the company linked toSupplyshortages that pressured …
Net loss was USD 8.3 million against USD 14.6 million. Management said growth slowed to 3% as better-for-you soda growth moderated and new distribution turned more slowly than expected.
Management said net interest income was USD 5.8 million and distributable earnings were USD 3.2 million, or USD 0.24 per basic share. Results included about USD 900,000, or USD 0.06 per share, of one-time merger-related costs. For the nine months, net income was about …
Total gross profit increased 32.4% to about USD 9.4 million, or 33.3% of sales, from about USD 7.1 million, or 27.2%. The filing states the margin increase was primarily due to a shift in customer mix and margin contribution.
Operating expenses were about USD 9.4 million against about USD 0.8 million a year earlier, including about USD 1.7 million of non-cash stock-based compensation. The company ended the quarter with USD 37.3 million in cash and cash equivalents against USD 25.3 million at June …